| Daniel B Bauwens, MD | |
|
232 S Woods Mill Rd, Chesterfield, MO 63017-3417 | |
| (314) 576-5023 | |
| Not Available |
| Full Name | Daniel B Bauwens |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine - Cardiovascular Disease |
| Location | 232 S Woods Mill Rd, Chesterfield, Missouri |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1003943523 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RC0000X | Internal Medicine - Cardiovascular Disease | R7172 (Missouri) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Daniel B Bauwens, MD 232 S Woods Mill Rd, Chesterfield, MO 63017-3417 Ph: (314) 576-5023 | Daniel B Bauwens, MD 232 S Woods Mill Rd, Chesterfield, MO 63017-3417 Ph: (314) 576-5023 |
News Archive
Resverlogix is pleased to announce that it has collaborated with the Division of Cardiology at the Research Institute of the McGill University Health Centre (RI of the MUHC), to publish today in the Journal of American College of Cardiology (JACC), a report entitled 'RVX-208 A Small Molecule that Increases Apolipoprotein A-I and High Density Lipoprotein Cholesterol In Vitro and In Vivo'.
Sen. Tom Harkin (D-IA), chair of the Senate Health, Education, Labor and Pensions Committee and long-time advocate of prevention, will keynote a National Journal Policy Summit focused on unraveling the complexities of the cost and value of prevention in a post health reform world. The Sept. 21 event is being underwritten by the American Clinical Laboratory Association and its educational arm, Results for Life.
Orexigen Therapeutics, Inc. today announced data from the CORDiabetes trial for Contrave (naltrexone sustained release (SR)/bupropion SR) showing that after 56 weeks of treatment, overweight or obese patients with type 2 diabetes lost significantly more weight and achieved greater improvement in glycemic control than those treated with placebo.
Brain areas that control attention were thinnest in children with attention deficit hyperactivity disorder (ADHD) who carried a particular version of a gene in a study by the National Institutes of Health's (NIH) National Institute of Mental Health (NIMH).
› Verified 7 days ago
Lovepreet Singh Randhawa, MD Cardiovascular Disease Medicare: Not Enrolled in Medicare Practice Location: 224 S Woods Mill Rd, Chesterfield, MO 63017 Phone: 314-205-6050 Fax: 314-205-6350 | |
Rachel Lynn Fishman Oiknine, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 222 S Woods Mill Rd, Suite 410n, Chesterfield, MO 63017 Phone: 314-469-6224 Fax: 314-469-0744 | |
Xiaoling Wu, MD Cardiovascular Disease Medicare: Medicare Enrolled Practice Location: 224 S Woods Mill Rd, Suite 370 South, Chesterfield, MO 63017 Phone: 314-878-2460 | |
Michael Carl Fusco, M.D. Cardiovascular Disease Medicare: Not Enrolled in Medicare Practice Location: 14528 S Outer 40, Suite 300, Chesterfield, MO 63017 Phone: 314-214-8100 Fax: 314-214-8233 | |
David H Cort, M.D. Cardiovascular Disease Medicare: Medicare Enrolled Practice Location: 226 S Woods Mill Rd, Suite 52 West, Chesterfield, MO 63017 Phone: 314-434-2399 Fax: 314-434-5653 | |
Meghashyam Jayateerth Koti, MD Cardiovascular Disease Medicare: Not Enrolled in Medicare Practice Location: 15740 S Outer 40 Rd # C, Chesterfield, MO 63017 Phone: 636-735-4963 |